Press Resease

Genome Editing Market - Global Industry Analysis

Genome Editing Market by Technology (CRISPR, TALEN, ZFN, Antisense, and Others), by Application (Cell Line Engineering, Genetic Engineering, and Others), and by End-User (Pharmaceutical & Biotechnological Companies, Academic and Research Institutes, and Contract Research Organizations): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 28-Jun-2019 Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-1185 Status : Published

Global genome editing market expected to generate around USD 9.66 billion by 2025, at a CAGR of around 14.7% between 2019 and 2025. The growing number of research activities for the treatment of chronic diseases using genome editing technology is fueling the global genome editing market.

Description

The report covers a forecast and an analysis of the genome editing market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the genome editing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the genome editing market on a global level.

In order to give the users of this report a comprehensive view of the genome editing market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Genome Editing Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.

The study provides a decisive view of the genome editing market by segmenting it on the basis of technology, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some major players of the global genome editing market are Thermo Fisher Scientific, Transposagen Biopharmaceuticals, Horizon Discovery, Editas Medicine, GenScript, Integrated DNA Technologies, Sangamo BioSciences, Lonza Group, OriGene Technologies, Merck, New England Biolabs, and CRISPR Therapeutics.

This report segments the global genome editing market into:

Global Genome Editing Market: Technology Analysis

  • CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)
  • TALEN (Transcriptor-Activator-Like Effector Nuclease)
  • ZFN (Zinc Finger Nucleases)
  • Antisense
  • Others

Global Genome Editing Market: Application Analysis

  • Cell Line Engineering
  • Genetic Engineering
  • Others

Global Genome Editing Market: End-User Analysis

  • Pharmaceutical and Biotechnological Companies
  • Academic and Research Institutes
  • Contract Research Organizations

Global Genome Editing Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global genome editing market, 2016-2025 (USD Billion)
    • 2.2. Global genome editing market: Snapshot
  •  
  • Chapter 3. Genome Editing Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global genome editing market drivers: Impact analysis
      • 3.2.2. Rising Government Funding and Increasing Number of Genomics Projects
      • 3.2.3. Growing Application Areas of Genomics
      • 3.2.4. High Prevalence of Infectious Diseases and Cancer
      • 3.2.5. Technological Advancements
      • 3.2.6. Increasing Production of Genetically-Modified Crops
    • 3.3. Market Restraints
      • 3.3.1. Global genome editing market restraints: Impact analysis
      • 3.3.2. The dearth of Trained Professionals
      • 3.3.3. Adverse Public Perception of Genetic Research
    • 3.4. Opportunities
      • 3.4.1. Use of Genome Editing in Specialized/Personalized Medicine
      • 3.4.2. Emerging Markets
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by technology
      • 3.6.2. Market attractiveness analysis, by application
      • 3.6.3. Market attractiveness analysis, by End-User
      • 3.6.4. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Genome Editing Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global genome editing market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New instruments launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Genome Editing Market - Technology Analysis
    • 5.1. Global genome editing market: Technology overview
      • 5.1.1. Global genome editing market revenue share, by technology, 2018 and 2025
    • 5.2. CRISPR
      • 5.2.1. Global genome editing market for CRISPR, 2016-2025 (USD Billion)
    • 5.3. TALEN
      • 5.3.1. Global genome editing market for TALEN, 2016-2025 (USD Billion)
    • 5.4. ZFN
      • 5.4.1. Global genome editing market for ZFN, 2016-2025 (USD Billion)
    • 5.5. Antisense
      • 5.5.1. Global genome editing market for antisense, 2016-2025 (USD Billion)
    • 5.6. Others
      • 5.6.1. Global genome editing market for others, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Genome Editing Market - Application Analysis
    • 6.1. Global genome editing market: Application overview
      • 6.1.1. Global genome editing market revenue share, by application, 2018 and 2025
    • 6.2. Cell Line Engineering
      • 6.2.1. Global genome editing market for cell line engineering, 2016-2025 (USD Billion)
    • 6.3. Genetic Engineering
      • 6.3.1. Global genome editing market for genetic engineering, 2016-2025 (USD Billion)
    • 6.4. Others
      • 6.4.1. Global genome editing market for others, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Genome Editing Market - End-User Analysis
    • 7.1. Global genome editing market: End-User overview
      • 7.1.1. Global genome editing market revenue share, by End-User, 2018 and 2025
    • 7.2. Academic and Research Institutes
      • 7.2.1. Global genome editing market for academic and research institutes, 2016-2025 (USD Billion)
    • 7.3. Pharmaceutical & Biotechnological Companies
      • 7.3.1. Global genome editing market for pharmaceutical & biotechnological companies, 2016-2025 (USD Billion)
    • 7.4. Contract Research Organizations
      • 7.4.1. Global genome editing market for contract research organizations, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global Genome Editing Market - Regional Analysis
    • 8.1. Global genome editing market: Regional overview
      • 8.1.1. Global genome editing market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America genome editing market, 2016-2025 (USD Billion)
      • 8.2.2. North America genome editing market revenue, by technology, 2016-2025 (USD Billion)
      • 8.2.3. North America genome editing market revenue, by application, 2016-2025 (USD Billion)
      • 8.2.4. North America genome editing market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. genome editing market revenue, by technology, 2016-2025 (USD Billion)
        • 8.2.5.2. The U.S. genome editing market revenue, by application, 2016-2025 (USD Billion)
        • 8.2.5.3. The U.S. genome editing market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.2.6. Canada
        • 8.2.6.1. Canada genome editing market revenue, by technology, 2016-2025 (USD Billion)
        • 8.2.6.2. Canada genome editing market revenue, by application, 2016-2025 (USD Billion)
        • 8.2.6.3. Canada genome editing market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe genome editing market, 2016-2025 (USD Billion)
      • 8.3.2. Europe genome editing market revenue, by technology, 2016-2025 (USD Billion)
      • 8.3.3. Europe genome editing market revenue, by application, 2016-2025 (USD Billion)
      • 8.3.4. Europe genome editing market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK genome editing market revenue, by technology, 2016-2025 (USD Billion)
        • 8.3.5.2. UK genome editing market revenue, by application, 2016-2025 (USD Billion)
        • 8.3.5.3. UK genome editing market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.6. Germany
        • 8.3.6.1. Germany genome editing market revenue, by technology, 2016-2025 (USD Billion)
        • 8.3.6.2. Germany genome editing market revenue, by application, 2016-2025 (USD Billion)
        • 8.3.6.3. Germany genome editing market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.7. France
        • 8.3.7.1. France genome editing market revenue, by technology, 2016-2025 (USD Billion)
        • 8.3.7.2. France genome editing market revenue, by application, 2016-2025 (USD Billion)
        • 8.3.7.3. France genome editing market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe genome editing market revenue, by technology, 2016-2025 (USD Billion)
        • 8.3.8.2. Rest of Europe genome editing market revenue, by application, 2016-2025 (USD Billion)
        • 8.3.8.3. Rest of Europe genome editing market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific genome editing market, 2016-2025 (USD Billion)
      • 8.4.2. Asia Pacific genome editing market revenue, by technology, 2016-2025 (USD Billion)
      • 8.4.3. Asia Pacific genome editing market revenue, by application, 2016-2025 (USD Billion)
      • 8.4.4. Asia Pacific genome editing market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.5. China
        • 8.4.5.1. China genome editing market revenue, by technology, 2016-2025 (USD Billion)
        • 8.4.5.2. China genome editing market revenue, by application, 2016-2025 (USD Billion)
        • 8.4.5.3. China genome editing market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.6. Japan
        • 8.4.6.1. Japan genome editing market revenue, by technology, 2016-2025 (USD Billion)
        • 8.4.6.2. Japan genome editing market revenue, by application, 2016-2025 (USD Billion)
        • 8.4.6.3. Japan genome editing market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.7. India
        • 8.4.7.1. India genome editing market revenue, by technology, 2016-2025 (USD Billion)
        • 8.4.7.2. India genome editing market revenue, by application, 2016-2025 (USD Billion)
        • 8.4.7.3. India genome editing market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific genome editing market revenue, by technology, 2016-2025 (USD Billion)
        • 8.4.8.2. Rest of Asia Pacific genome editing market revenue, by application, 2016-2025 (USD Billion)
        • 8.4.8.3. Rest of Asia Pacific genome editing market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America genome editing market, 2016-2025 (USD Billion)
      • 8.5.2. Latin America genome editing market revenue, by technology, 2016-2025 (USD Billion)
      • 8.5.3. Latin America genome editing market revenue, by application, 2016-2025 (USD Billion)
      • 8.5.4. Latin America genome editing market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil genome editing market revenue, by technology, 2016-2025 (USD Billion)
        • 8.5.5.2. Brazil genome editing market revenue, by application, 2016-2025 (USD Billion)
        • 8.5.5.3. Brazil genome editing market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America genome editing market revenue, by technology, 2016-2025 (USD Billion)
        • 8.5.6.2. Rest of Latin America genome editing market revenue, by application, 2016-2025 (USD Billion)
        • 8.5.6.3. Rest of Latin America genome editing market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa genome editing market, 2016-2025 (USD Billion)
      • 8.6.2. The Middle East and Africa genome editing market revenue, by technology, 2016-2025 (USD Billion)
      • 8.6.3. The Middle East and Africa genome editing market revenue, by application, 2016-2025 (USD Billion)
      • 8.6.4. The Middle East and Africa genome editing market revenue, by End-User, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Thermo Fisher Scientific
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Transposagen Biopharmaceuticals
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Horizon Discovery Group
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Editas Medicine
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. GenScript
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. Integrated DNA Technologies
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. Sangamo BioSciences
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Lonza Group
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. OriGene Technologies
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. Merck
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments
    • 9.11. New England Biolabs
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Product Portfolio
      • 9.11.4. Business Strategy
      • 9.11.5. Recent Developments
    • 9.12. CRISPR Therapeutics
      • 9.12.1. Overview
      • 9.12.2. Financials
      • 9.12.3. Product Portfolio
      • 9.12.4. Business Strategy
      • 9.12.5. Recent Developments

Methodology

Free Analysis

Genome editing is used precisely to modify the DNA present within a particular cell. Genome editing mainly involves cutting the specific sequence of DNA with the help of enzymes, which are also called engineered nucleases. This technique can also be used to remove, alter, or add a particular DNA segment in a genome.

As per the WHO, about 14 million cancer cases were reported in 2012 and by 2030 the incidence is estimated to reach 70% of the total global population. According to the CDC, in 2016, over 10.4 million people suffered from tuberculosis. The growing number of research activities for the treatment of chronic diseases using genome editing technology is fueling the global genome editing market. Growing demand for synthetic genes, increase in the preference for personalized and precision medicines, rise in research activities related to genome editing, and rapid development of genome editing technologies are also driving the global genome editing market. However, the lack of skilled professionals, high equipment cost, and negative public opinion about genetic research may hinder the global genome editing market.

Global Genome Editing Market

The global genome editing market is divided based on technology, application, and end-user. Based on technology, the genome editing market includes ZFN, antisense, CRISPR, TALEN, and others. ZFN is anticipated to show notable growth over the forecast time period, owing to its various benefits like the mutations made by ZFN technology are heritable and permanent. By application, the market is fragmented into genetic engineering, cell line engineering, and others. Cell line engineering is expected to witness the highest growth rate in the future, owing to the increasing research activities of stem cells for the treatment of various diseases, growing awareness about stem cell therapy benefits, and rising government funding for stem cell research. The end-user segment comprises contract research organizations, pharmaceutical and biotechnological companies, and academic and research institutes. Academic and research institutes are anticipated to register good growth, owing to the growing research activities related to genetic engineering and stem cell therapies and increasing government funding for these research projects.

North America is projected to dominate the global genome editing market in the years ahead, owing to the early introduction of highly developed equipment and techniques, availability of a highly skilled workforce, and the presence of major companies. The Asia Pacific region is anticipated to show the highest CAGR in the upcoming years, due to the rising government investments for stem cell research, growing establishments of pharmaceutical companies in India and China, and the presence of a large patient pool suffering from chronic diseases.

Some major players of the global genome editing market are Thermo Fisher Scientific, Transposagen Biopharmaceuticals, Horizon Discovery, Editas Medicine, GenScript, Integrated DNA Technologies, Sangamo BioSciences, Lonza Group, OriGene Technologies, Merck, New England Biolabs, and CRISPR Therapeutics.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social